The Hepatitis B Foundation is proud to announce that Baruch Blumberg, M.D., Ph.D., has joined the organization as the first Distinguished Scholar. He will spend several days a month at the HBF, meeting with foundation researchers and public health professionals to inspire and guide them in their valuable work.

Dr. Blumberg received the Nobel Prize in medicine in 1976 for his discovery of the hepatitis B virus, and invention of the first vaccine against hepatitis B. By joining the foundation, he has the opportunity to contribute to the completion of his circle of discovery – finding a cure for hepatitis B.

“I greatly admire the Hepatitis B Foundation and its mission. It is a world-class research organization with one of the largest concentrations of scientists working on the problem of hepatitis B. This is an exciting time for hepatitis B research, and I support the foundation’s goal of eradicating hepatitis B,” said Blumberg.

Dr. Blumberg has been involved with the Hepatitis B Foundation since the very beginning and for the past 15 years has served on the foundation’s Medical and Scientific Advisory Board. He has been an important ally in supporting its national research and public health initiatives as a scientist with an extraordinary commitment to hepatitis B.